Prevantics® device swab from PDI receives FDA 510k market authorization

0

PDI report “PDI, manufacturer of market-leading infection prevention products and solutions, announced the introduction of Prevantics® Device Swab, the only Chlorhexidine Gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use on ports and hubs.”

Click here for the full press release.

Thank you to our partners for supporting IVTEAM

Main page

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.